GoodRx's CEO announced a new partnership with TrumpRx and Surescripts, aiming to expand prescription access across the U.S. The collaboration integrates digital health tools and real-time pharmacy pricing data to enhance patient affordability. Key performance metrics from pilot programs show a 32% increase in medication adherence and a 19% reduction in out-of-pocket costs for enrolled users.
- The collaboration connects GoodRx’s price transparency platform with TrumpRx’s national distribution network and Surescripts’ EHR integration ecosystem.
- Pilot data shows a 32% improvement in medication adherence among participants using the integrated system.
- Average out-of-pocket costs dropped by 19% compared to standard pharmacy purchases without discount programs.
- The initiative targets 45 million covered lives within the first year, spanning employer-sponsored plans and Medicaid managed care organizations.
- Integration is being rolled out in 48 states, with full national coverage expected by Q3 2026.
- Key technical enhancements include API-level connectivity allowing prescribers to view GoodRx discounts directly within electronic health records.
GoodRx's CEO unveiled a transformative alliance between GoodRx, TrumpRx, and Surescripts during a regulatory briefing on January 13, 2026, marking a pivotal step in modernizing America’s prescription drug infrastructure. The three entities are aligning their platforms to deliver real-time, transparent pricing and seamless prescription fulfillment services. This integration leverages Surescripts’ nationwide network of over 250,000 prescribers and 70,000 pharmacies, enabling millions of patients to access discounted medications through automated co-pay savings tools.